Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Cambridge have revealed the molecular details of a genetic switch through their work on the 2A protein...
The rapid expansion of the Omicron variant has taken the international medical and scientific community by surprise. After infection or vaccination against the coronavirus, our bodies produce antibodies that play a key...
Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI) and the Helmholtz Centre for Infection Research (HZI) in Braunschweig demonstrate for the first time how ZAP, a protein of the...
Since 2017, interested citizen scientists can collect soil samples as part of the "Sample’ das Saarland" campaign and send them to the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The HIPS is a site...
Between July 2020 and August 2021, the Epidemiology Department of the Helmholtz Centre for Infection Research (HZI) in Braunschweig examined the blood of approximately 26,000 individuals for antibodies against the...
A conversation about the direction of research at the HZI with Prof Thomas Pietschmann, who is the head of the "Experimental Virology" department at the HZI and director of the Experimental Virology Institute at the...
The cold season has arrived along with the question of whether a vaccination against influenza makes sense in times of the ongoing pandemic. And when is the right time for the third vaccination, i.e. the booster...
On the occasion of its 15th anniversary, the MTZ®foundation presented the SonderMTZ®-Award 2021 in Erkrath-Trills. The award winner is Dr Sahamoddin Khailaie from the department "Systems Immunology" headed by Prof...
Cholesterol-lowering drugs do not promote infection with the novel coronavirus SARS-CoV-2. This is the conclusion of a team of researchers from TWINCORE - Center for Experimental and Clinical Infection Research and the...
